Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-12-000487
Filing Date
2012-03-27
Accepted
2012-03-27 07:32:18
Documents
15
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 biostarpharna10k123111.htm 10-K 1911251
2 ex21.htm EX-21 5259
3 ex23-1.htm EX-23.1 4129
4 ex23-2.htm EX-23.2 6454
5 ex31-1.htm EX-31.1 14011
6 ex31-2.htm EX-31.2 13899
7 ex32-1.htm EX-32.1 5501
8 ex32-2.htm EX-32.2 6046
15 graph2011.jpg GRAPHIC 38482
  Complete submission text file 0001185185-12-000487.txt   5370049

Data Files

Seq Description Document Type Size
9 bspm-20111231.xml EX-101.INS 791854
10 bspm-20111231.xsd EX-101.SCH 21613
11 bspm-20111231_cal.xml EX-101.CAL 31559
12 bspm-20111231_def.xml EX-101.DEF 100609
13 bspm-20111231_lab.xml EX-101.LAB 139885
14 bspm-20111231_pre.xml EX-101.PRE 115836
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34708 | Film No.: 12715749
SIC: 2834 Pharmaceutical Preparations